Nandrolone (Deca-Durabolin)

Nandrolone, best known by the brand name Deca-Durabolin, is a man-made anabolic-androgenic steroid (AAS — a drug that builds muscle and acts like testosterone). Chemically it’s 19-nortestosterone, a close cousin of testosterone. It is not a peptide and not a SARM. There’s real, solid human research showing it builds lean mass (muscle and other non-fat tissue) in people who are sick and wasting away. It’s also easier on the liver than steroids you swallow as pills. But it’s still an outside source of androgen (a testosterone-like hormone), so it strongly shuts down your own hormones, brings the usual sexual side effects, and carries the heart risks that come with long-term steroid use.

What it is

Nandrolone is 19-nortestosterone (the chemists’ name is 17β-hydroxyestr-4-en-3-one). It’s basically testosterone with one small piece (the C19 methyl group) removed. That makes it the original member of the “19-nor” steroid family. In medicine it comes as an oil-based shot, where the drug is attached to a fatty tail called an ester. The two common versions are nandrolone decanoate (Deca-Durabolin) and the faster-acting nandrolone phenylpropionate (Durabolin). Once it’s in the body, that ester tail gets snipped off to release the free drug. The ester only changes how fast the drug is released — it doesn’t change how the drug actually works.

One key point: nandrolone is not 17α-alkylated. That’s a chemistry tweak (an added carbon group that lets a steroid survive being swallowed) that makes oral steroids like stanozolol, oxymetholone, or methyltestosterone hard on the liver. Because nandrolone skips that tweak, it skips much of that liver danger. In terms of how it works, nandrolone switches on the androgen receptor (AR), the cell’s docking point for testosterone-like hormones. It grabs that receptor fairly tightly, and in old rodent tests it looked like it builds muscle more than it causes male-type side effects (those test ratios depend on the animal model, though, and don’t predict the human picture exactly). Two things set it apart from testosterone:

• Milder effect on “male” tissues. Testosterone gets boosted into a stronger hormone called DHT by an enzyme (5α-reductase). Nandrolone goes the opposite way: that same enzyme turns it into 5α-dihydronandrolone (DHN), a weaker form. So in tissues full of this enzyme — scalp, skin, prostate — nandrolone acts less strongly than testosterone.
• Progesterone-like activity. Nandrolone latches onto the progesterone receptor (the docking point for the hormone progesterone) at about 22% of the strength of progesterone itself — more than testosterone does. This drives some of its trademark side effects: loss of sex drive and erection problems (jokingly called “deca dick”), and it adds to the risk of breast-tissue growth in men. It also converts into estrogen (the main female sex hormone) much less than testosterone does, so estrogen-type effects are lower for a given amount of muscle-building effect — but not zero, and the progesterone-like activity still adds to the breast-growth risk.

The claims

In medicine, nandrolone has been used — both in the past and today — for the anemia (low red blood cell count) of long-term kidney disease, where it raises hemoglobin and red-cell mass. It’s also been studied in people wasting away from illness (HIV, dialysis) and as a general muscle-building add-on. Newer drugs — medicines that stimulate red blood cell production for anemia, and modern treatments for wasting — have mostly taken its place in everyday care.

In the gym and bodybuilding world, people use it illegally to add lean mass, and many prize it as a “joint comfort” add-on. Fans point to its slow-release ester and its gentler effect on male-type tissues and the liver (compared with pills) as pluses. This profile is a reference, not a how-to — it gives no doses, cycles, ester timing, or post-cycle plans.

What the evidence actually shows

The human research showing nandrolone builds lean/muscle mass is consistent and high quality:

• Dialysis patients (RCT). Johansen, Mulligan, and Schambelan (JAMA, 1999) ran a randomized, double-blind, placebo-controlled trial (a strong study design where neither patients nor doctors know who got the real drug versus a dummy) in patients on hemodialysis. Nandrolone clearly increased lean body mass (average gain +4.5 kg vs +1.9 kg with placebo over 6 months; P=.005), along with better physical function (PMID 10208142).
• HIV-associated wasting, men. Storer et al. (J Clin Endocrinol Metab, 2005) ran a placebo-controlled RCT that also included growth hormone (rhGH) as a comparison treatment. Nandrolone raised lean body mass (+1.6 kg vs +0.4 kg with placebo; rhGH +2.5 kg) — better than placebo, and statistically no different from the FDA-approved growth hormone regimen (PMID 15914526).
• HIV-associated wasting, women. Mulligan et al. (Arch Intern Med, 2005), a randomized, double-blind, placebo-controlled multicenter trial in HIV-infected women who were losing weight, found gains in weight (+4.6 kg) and lean body mass (+3.5 kg; P<.001) (PMID 15767536).
• Recent synthesis (2026). Prokopidis et al. (J Cachexia Sarcopenia Muscle, 2026; DOI 10.1002/jcsm.70276) pooled together the randomized trials up through April 2025 (a systematic review and meta-analysis — a study that combines many trials into one big picture). They found nandrolone decanoate clearly increased lean soft tissue (+1.59 kg; 95% CI 1.06–2.13) but showed no meaningful effect on fat mass, grip strength, or knee-extension strength, with mixed results on bone density (only the total upper-thigh-bone density improved). The quality of the evidence was rated low (GRADE), and the authors concluded the gains are modest with little real-world functional payoff, favoring non-drug approaches.

Bottom line on effect: the proof that it adds lean/muscle mass is solid; the proof that this turns into real strength, everyday function, or bone gains is weaker and all over the place.

Legal and regulatory status

In the United States, nandrolone is a Schedule III controlled substance under the Controlled Substances Act (meaning it’s regulated and has accepted medical uses but a potential for abuse). The Anabolic Steroids Control Act of 1990 put AAS into Schedule III, and the Anabolic Steroid Control Act of 2004 (signed October 22, 2004) widened and clarified the official list. Nandrolone is named outright in the current legal definition at 21 U.S.C. § 802(41)(A)(xxxiv): “nandrolone (17β-hydroxyestr-4-en-3-one).” It’s legal only with a valid prescription; selling or possessing it for non-medical use is a federal crime. Generic nandrolone decanoate is still a legally prescribable Schedule III product, approved on the label for anemia of kidney disease.

For context (these are not nandrolone facts): clenbuterol is neither FDA-approved for human use nor a scheduled controlled substance, and recombinant hGH (lab-made human growth hormone) is not controlled under the CSA — its non-medical sale is made a crime separately under 21 U.S.C. § 333(e), not through the steroid rules.

In sport, nandrolone is a banned anabolic agent on the WADA Prohibited List, class S1.1 (anabolic androgenic steroids), prohibited at all times (both in and out of competition). Drug tests catch it in urine through its main breakdown product, 19-norandrosterone (19-NA). Because tiny amounts of 19-NA can show up naturally in the body, WADA sets a decision/reporting limit of 2 ng/mL, the same for both male and female athletes (the women’s threshold was lowered from 5 to 2 ng/mL in 2004). A reading above that limit triggers a follow-up test by GC/C/IRMS (a lab method that tells man-made hormone from the body’s own). In the first screening round, a level around 2.5 ng/mL acts as an alarm that prompts more testing — it’s a screening trigger, not the official reporting cutoff.

Safety

Its chemistry spares nandrolone the liver danger of oral steroids, but it’s still an outside source of androgen with real, well-documented harms.

• Hormone shutdown / infertility: It strongly suppresses the body’s own hormone-control system (the HPTA — the hypothalamic-pituitary-testicular axis, which manages LH, FSH, and your own testosterone), lowering sperm production and possibly causing infertility. Its progesterone-like activity makes this shutdown — and the recovery from it — especially stubborn, and the suppression can drag on.
• Sexual problems (“deca dick”): Low natural testosterone plus the progesterone-like activity often leads to loss of sex drive and erectile dysfunction.
• Cholesterol and heart: Steroids in general lower HDL (“good” cholesterol) and can raise LDL (“bad” cholesterol) and blood pressure, and with long-term use they can thicken the heart’s main pumping chamber (LV hypertrophy) and clog arteries. Nandrolone’s effect on cholesterol is usually milder than that of the 17α-alkylated oral steroids — one study (Glazer & Suchman, Metabolism, 1994; PMID 8121303) found no meaningful change in HDL/LDL with weekly nandrolone decanoate over 6 weeks — but it’s not cholesterol-neutral, and long-term use of high steroid doses carries a real heart risk.
• Liver injury: Low for nandrolone, because it’s not 17α-alkylated. It avoids the bile-flow problems, blood-filled liver cysts (peliosis hepatis), abnormal regrowth, benign tumors, and liver cancer linked to oral 17α-alkylated steroids. Per NIH LiverTox, those liver injuries come from the 17α-alkylated androgens, while esterified/injected testosterone-type androgens carry much lower risk (mild changes in liver enzymes are possible).
• Too many red blood cells: It raises hemoglobin and hematocrit (which is why it treats anemia), but using more than the medical amount can cause polycythemia (too-thick blood) and a higher clot risk.
• Breast growth / estrogen- and progesterone-type effects: Even with low conversion to estrogen, breast-tissue growth and fluid retention happen, partly driven by the progesterone-like activity.
• Masculinizing effects (women): Deeper voice, extra body hair, enlargement of the clitoris, and disrupted periods — some of these changes don’t reverse.
• Other: Acne, mood and behavior changes, possible effects on blood sugar, injection-related risks, and the dangers of contaminated or mislabeled black-market product.

Bottom line

Nandrolone has a real, high-quality human evidence base — but the consistent finding is more lean mass in people sick and wasting (dialysis, HIV wasting), not proven strength, function, or bone gains, and not performance gains in healthy people, where solid evidence is missing. It’s a Schedule III prescription anabolic steroid, banned at all times in sport, and it carries real androgenic, hormone-shutdown, and heart risks. Being easier on the liver than oral steroids does not make it “safe.”

Evidence grade: 8/10 · Good.

Sources

• Johansen KL, Mulligan K, Schambelan M — anabolic effects of nandrolone decanoate in dialysis patients, RCT (JAMA 1999; PMID 10208142)
• Storer TW et al. — nandrolone decanoate in HIV-infected men with weight loss, RCT with rhGH reference (J Clin Endocrinol Metab 2005; PMID 15914526)
• Mulligan K et al. — nandrolone decanoate in HIV-infected women with weight loss, RCT (Arch Intern Med 2005; PMID 15767536)
• Prokopidis K et al. — nandrolone decanoate on strength, body composition, and bone density: systematic review/meta-analysis (J Cachexia Sarcopenia Muscle 2026; DOI 10.1002/jcsm.70276)
• Glazer G, Suchman AL — lack of demonstrated effect of nandrolone on serum lipids (Metabolism 1994; PMID 8121303)
• NIH LiverTox — Androgenic Steroids (NCBI Bookshelf NBK548931)
• FDA Federal Register — Deca-Durabolin not withdrawn for reasons of safety or effectiveness (2010)
• DailyMed — Nandrolone Decanoate Injection USP (C-III) prescribing information
• 21 U.S.C. § 802(41) — statutory definition of “anabolic steroid” listing nandrolone (Cornell LII)
• Anabolic Steroid Control Act of 2004 (S.2195, 108th Congress), full text
• Anabolic Steroids Control Act of 1990 — Schedule III placement
• Nandrolone — chemistry, progestogenic activity, 5α-reduction to DHN, reduced aromatization
• 17α-Alkylated anabolic steroid — basis of oral AAS hepatotoxicity (nandrolone is non-alkylated)